医学
芳香化酶
氨基谷酰胺
阿那曲唑
依西美坦
来曲唑
三苯氧胺
乳腺癌
抗雌激素
芳香化酶抑制剂
肿瘤科
内科学
癌症
内分泌系统
妇科
激素
作者
Ian E. Smith,Mitch Dowsett
摘要
Until recently, tamoxifen, a nonsteroidal antiestrogen, was the mainstay of endocrine treatment of breast cancer. However, new aromatase inhibitors that are many times more potent and specific than the first such agent, aminoglutethimide, are changing the management of breast cancer in postmenopausal women. This review discusses the role of aromatase inhibitors such as letrozole, anastrozole, and exemestane in the treatment of breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI